EDGAR Filing Documents for 0001193125-18-265035

Form 8-K - Current report:

SEC Accession No. 0001193125-18-265035

Filing Date

2018-08-31

Accepted

2018-08-31 16:11:36

Documents

Period of Report

2018-08-28

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d612321d8k.htm	8-K	29000
2	EX-10.1	d612321dex101.htm	EX-10.1	27406
3	EX-10.2	d612321dex102.htm	EX-10.2	27245
4	EX-10.3	d612321dex103.htm	EX-10.3	27164
5	GRAPHIC	g612321g95a62.jpg	GRAPHIC	7784
	Complete submission text file	0001193125-18-265035.txt		122953

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655

CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 181050270
SIC: 2834 Pharmaceutical Preparations